☆ 4.7 Article

Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Related references

Note: Only part of the references are listed.

Article Otorhinolaryngology

Recovery rate and factors associated with smell and taste disruption in patients with coronavirus disease 2019

Pablo Parente-Arias et al.

Summary: The study found that olfactory and gustatory dysfunction was common in COVID-19 patients, with associations to age, sex, and clinical severity. Smell disruption had a high recovery rate, with most patients experiencing symptom relief within two months, while around 15% remained symptomatic after three months of follow-up.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Olfactory Bulb MRI and Paranasal Sinus CT Findings in Persistent COVID-19 Anosmia

Sedat Giray Kandemirli et al.

Summary: This study evaluated 23 patients with persistent COVID-19 olfactory dysfunction, finding olfactory cleft and olfactory bulb abnormalities to be common in cases of COVID-19 anosmia. The study also revealed a relatively high percentage of olfactory bulb degeneration, indicating a need for further longitudinal imaging studies to better understand the mechanism of olfactory neuronal pathway injury in COVID-19 anosmia.

ACADEMIC RADIOLOGY (2021)

Add to Collection

Article Otorhinolaryngology

Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines

Claire Hopkins et al.

Summary: This study aims to provide recommendations for the investigation and management of patients with new onset loss of sense of smell during the COVID-19 pandemic. A panel of 15 experts used the RAND/UCLA methodology to reach consensus on treatment options, referral guidelines, and imaging. Consensus was achieved on most statements after 2 rounds of ranking, with olfactory training recommended for all patients with persistent loss of sense of smell, and individual consideration for oral steroids, steroid rinses, and omega 3 supplements.

CLINICAL OTOLARYNGOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients

Jeyasakthy Saniasiaya et al.

Summary: A systematic review and meta-analysis found that the overall prevalence of olfactory dysfunction in COVID-19 patients is 47.85%, with European patients having the highest prevalence and Asian patients the lowest. Discrepancies between objective and subjective evaluations suggest further studies are needed.

LARYNGOSCOPE (2021)

Add to Collection

Article Microbiology

Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients

Luigi Angelo Vaira et al.

Summary: Objective evaluation of olfactory function in COVID-19 patients is challenging due to logistical and safety issues. Psychophysical tests provide more accurate results than patient self-reports. Olfactory disturbances appear to be largely independent of epidemiological and clinical characteristics.

PATHOGENS (2021)

Add to Collection

Article Otorhinolaryngology

Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial

Abdelrahman Ahmed Abdelalim et al.

Summary: The study found that using mometasone furoate nasal spray as a topical corticosteroid for post COVID-19 anosmia did not offer significant benefits over olfactory training, with no statistical differences in treatment outcomes and recovery rates.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Add to Collection

Article Behavioral Sciences

Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19

Paolo Boscolo-Rizzo et al.

Summary: This study found that as the time since virus infection increases, olfactory dysfunction becomes more common among patients, with a high percentage showing persistent dysfunction despite most patients subjectively reporting normal smell.

CHEMICAL SENSES (2021)

Add to Collection

Article Allergy

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

Carlo Cervia et al.

Summary: The study found that severe COVID-19 patients experienced a significant increase in SARS-CoV-2 antibody titers after symptom onset, especially with high IgA titers, while mild cases may exhibit transient production of SARS-CoV-2-specific antibodies. Interestingly, some healthcare workers with negative serum antibody titers showed SARS-CoV-2-specific IgA in mucosal fluids with virus-neutralizing capacity in some cases.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals

Savannah E. Butler et al.

Summary: Understanding humoral immune responses to SARS-CoV-2 infection is crucial for vaccine development and antibody-based interventions. Antibody responses in convalescent individuals varied depending on disease severity, with systemic and mucosal responses showing different characteristics. Neutralization and antibody-mediated effector functions in serum correlated with IgG response magnitude, while nasal neutralization was associated with IgA response, highlighting the importance of assessing mucosal immunity in larger natural infection cohorts.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Otorhinolaryngology

Validity and reliability of the COVID-19 symptom index, an instrument evaluating severity of general and otolaryngological symptoms

Jerome R. Lechien et al.

Summary: A clinical instrument, the CSI, was developed to evaluate symptoms of COVID-19 patients, showing high internal consistency, validity, and responsiveness to change.

ACTA OTO-LARYNGOLOGICA (2021)

Add to Collection

Article Infectious Diseases

Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection

Catharina Gerhards et al.

Summary: This study provides insight into the long-term antibody response to SARS-CoV-2 infection, with stable antibody titers observed over an 8-month period. Nearly half of the participants experienced postCOVID syndrome, with olfactory and gustatory dysfunctions being the most commonly reported symptoms.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Otorhinolaryngology

Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study

M. Petrocelli et al.

Summary: A study found that six months after the onset of COVID-19, about 6% of patients still had severe persistent olfactory or gustatory disturbances.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2021)

Add to Collection

Article Otorhinolaryngology

Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?

L. A. Vaira et al.

Summary: The study showed that D-dimer, procalcitonin, ferritin, and neutrophil-to-lymphocyte ratio were significantly correlated with severe COVID-19, while olfactory disturbances appeared to have little prognostic value in predicting disease severity. The lack of correlation between olfactory disturbances and inflammatory markers suggests that the underlying pathogenesis of smell loss in COVID-19 patients may be more related to local rather than systemic factors.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2021)

Add to Collection

Article Microbiology

Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study

Sven Saussez et al.

Summary: The early use of oral corticosteroids or nasal corticosteroids in combination with olfactory training seems to have better efficacy in improving COVID-19 related olfactory dysfunction compared to olfactory training alone, but the long-term outcomes remain uncertain, requiring further research to validate.

PATHOGENS (2021)

Add to Collection

Review Pathology

ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review

Jerome R. Lechien et al.

Summary: The review found that ACE2 and TMPRSS2 are widely expressed in head and neck tissues, playing an important role in viral entry into the host organism. There are differences in expression levels among different cell types and locations, with TMPRSS2 expressed in respiratory cells and ACE2 more prominent in oral and sinus nasal mucosa.

HEAD & NECK PATHOLOGY (2021)

Add to Collection

Article Behavioral Sciences

Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19

Paolo Boscolo-Rizzo et al.

Summary: This study prospectively assessed the 6-month prevalence of olfactory dysfunction in subjects with mild-to-moderate COVID-19. Despite most patients reporting a subjectively normal sense of smell, a high percentage of persistent smell dysfunction was observed at 6 months, highlighting a significant long-term rate of smell alteration in patients with previous SARS-CoV-2 infection.

CHEMICAL SENSES (2021)

Add to Collection

Article Infectious Diseases

Characteristics of COVID-19 infection in Beijing

Sijia Tian et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Letter Medicine, General & Internal

Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection

Giacomo Spinato et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Letter Otorhinolaryngology

Potential pathogenesis of ageusia and anosmia in COVID-19 patients

Luigi Angelo Vaira et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia

Abolfazl Torabi et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism

Katarzyna Bilinska et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Add to Collection

Article Behavioral Sciences

More Than Smell - COVID-19 Is Associated With Severe Impairment of Smell,Taste, and Chemesthesis

Valentina Parma et al.

CHEMICAL SENSES (2020)

Add to Collection

Article Clinical Neurology

Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak

C. M. Chiesa-Estomba et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Add to Collection

Article Infectious Diseases

Acute onset olfactory/taste disorders are associated with a high viral burden in mild or asymptomatic SARS-CoV-2 infections

Kensuke Nakagawara et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Otorhinolaryngology

Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study

L. A. Vaira et al.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2020)

Add to Collection

Letter Medicine, General & Internal

Inflammatory olfactory neuropathy in two patients with COVID-19

Daniel Kirschenbaum et al.

LANCET (2020)

Add to Collection

Article Medicine, Research & Experimental

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Sabra Klein et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Medicine, Research & Experimental

COVID-19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction

Ryan H. W. Cho et al.

LARYNGOSCOPE (2020)

Add to Collection

Article Otorhinolaryngology

Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia

L. A. Vaira et al.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell

Jerome R. Lechien et al.

FRONTIERS IN MEDICINE (2020)

Add to Collection

Correction Immunology

Interferon-α2b Treatment for COVID-19 (vol 11, 1061, 2020)

Qiong Zhou et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Review Immunology

Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA

Kang Chen et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Add to Collection

Article Otorhinolaryngology

Updated Sniffin' Sticks normative data based on an extended sample of 9139 subjects

A. Oleszkiewicz et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2019)

Add to Collection

Article Otorhinolaryngology

Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20)

JF Piccirillo et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.